MedPath

An exploratory study for the development of novel individually optimized treatment using transcranial magnetic stimulation (TMS) for patients with mood disorders

Not Applicable
Conditions
Mood disorders (major depressive disorder and bipolar disorder) and healthy volunteers
Registration Number
JPRN-UMIN000019481
Lead Sponsor
Department of Psychiatry and Neurosciences, Graduate school of Biomedical and Health Sciences, Hiroshima University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
70
Inclusion Criteria

Not provided

Exclusion Criteria

Rejection criteria common to both patients and healthy controls 1)Decisionally impaired individuals who has diminished capacity to understand the aim of the research 2)Physically impaired individuals who are not able to complete the experiments 3)Subjects who are contraindicated for the use of TMS and MRI Having an implanted heart pace-maker Having implanted cerebral (arteries) clips Having implanted neural/nerve stimulators Having implanted pumps Having work experience in a metal industry or possibility of metal residues remaining in the body Having metal-tattoos (including tattooed eye-lining) Being pregnant, or having possibility of being pregnant 4)Subjects who are contraindicated for the use of TMS Personal history of seizure disorder such as epileptic disorder 5)Any individuals judged as inappropriate for the experiment by the principal investigator or a collaborating researcher

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
sing psychological assessments and neuroimaging techniques, we evaluate psychological and neural changes in depression-related symptoms, immediately after the intervention, one week later, one month later, and again six months later.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath